Listed

Nurix Therapeutics, Inc.

NRIXNasdaqCIK 1549595HealthcareFiscal year ends Nov 30

Reports and events: 115 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Nurix Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2021-05-1006:04 ET8-K5.07 Shareholder vote results0001193125-21-155518
2021-04-1316:24 ET10-QQuarterly reportPeriod 2021-02-280001564590-21-018713
2021-04-1316:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-018690
2021-03-2506:03 ETDEF 14AProxy statementPeriod 2021-05-060001193125-21-093256
2021-03-0216:02 ETS-1Registration statement0001193125-21-065468
2021-02-1616:11 ET10-KAnnual reportPeriod 2020-11-300001564590-21-006071
2021-02-1616:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-006066
2020-12-0706:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-311095
2020-10-2616:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-20-276906
2020-10-1416:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-20-046402
2020-10-1416:02 ET10-QQuarterly reportPeriod 2020-08-310001564590-20-046400
2020-10-1414:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-269223
2020-07-2306:12 ETS-1/ARegistration statement, amended0001193125-20-197412
2020-07-2006:32 ETS-1/ARegistration statement, amended0001193125-20-195056
2020-07-0216:04 ETS-1Registration statement0001193125-20-186809

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 13:59 ET. Listed shows no prices and gives no investment advice.